Early Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis
NCT ID: NCT07101315
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2022-01-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Do participants who have early surgery have a similar rate of complications compared to those who have delayed surgery?
* How does the timing of surgery affect the length of the hospital stay?
Researchers will compare two groups:
1. An early surgery group
2. A delayed surgery group
Participants in the early surgery group had their gallbladder removed within 72 hours of when their symptoms started. Participants in the delayed surgery group were first treated with medications and had their surgery 6-8 weeks later.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study
NCT02130245
Early Versus Delayed Cholecystectomy
NCT03122054
Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days?
NCT03999645
Early Versus Interval Laparoscopic Cholecystectomy for Acute Cholecystitis
NCT07021300
Prolonged Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis
NCT05736003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Laparoscopic Cholecystectomy (ELC)
Participants underwent laparoscopic cholecystectomy within 72 hours of symptom onset during the index hospital admission.
Laparoscopic Cholecystectomy
Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.
Delayed Laparoscopic Cholecystectomy (DLC)
Participants received initial non-operative management with antibiotics and analgesics, followed by elective laparoscopic cholecystectomy 6-8 weeks later.
Laparoscopic Cholecystectomy
Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic Cholecystectomy
Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A clinical diagnosis of acute cholecystitis confirmed by clinical presentation, laboratory findings, and imaging studies
* Symptom duration of less than 72 hours at presentation
* Fitness for general anesthesia (American Society of Anesthesiologists \[ASA\] physical status classification I-III)
* Provision of written informed consent
Exclusion Criteria
* Severe comorbidities precluding surgery (ASA class IV-V)
* Coagulopathy (INR \>1.5 or platelet count \<100,000/μL)
* Pregnancy
* Previous major upper abdominal surgery
* Patient refusal to participate
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Thawra Modern General Hospital
OTHER
Al-Kuwait University Hospital
UNKNOWN
Sana'a University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haitham Mohammed Jowah
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammed A Issa, Professor
Role: PRINCIPAL_INVESTIGATOR
Sana'a University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al-Kuwait University Hospital
Sanaa, , Yemen
Al-Thawra Modern General Hospital
Sanaa, , Yemen
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SanaaU-Chole-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.